Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Atherosclerosis
|
January 14, 2015
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes
Baris Gencer, Reto Auer, David Nanchen, et al.
Journal of the American Heart Association
|
November 11, 2017
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes
Baris Gencer, Konstantinos C Koskinas, Lorenz Räber, et al.
Internal and Emergency Medicine
|
February 19, 2022
Eight versus 28-point lung ultrasonography in moderate acute heart failure: a prospective comparative study
Antonio Leidi, Guillaume Soret, Tamara Mann, et al.
AIDS Research and Therapy
|
February 24, 2015
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
David Carballo, Cécile Delhumeau, Sebastian Carballo, et al.
Atherosclerosis Plus
|
October 1, 2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes
Cédric Follonier, Gabriel Rabassa, Mattia Branca, et al.
European Heart Journal
|
February 10, 2011
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity
Alessandra Quercioli, Zoltan Pataky, Gabriella Vincenti, et al.
Plos One
|
March 29, 2014
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications
Reto Auer, Baris Gencer, Lorenz Räber, et al.
European Journal of Preventive Cardiology
|
April 10, 2021
Prognostic value of total testosterone levels in patients with acute coronary syndromes
Baris Gencer, Nicolas Vuilleumier, David Nanchen, et al.
Plos One
|
February 22, 2019
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention
David Carballo, Nicolas Rodondi, Reto Auer, et al.
European Journal of Clinical Investigation
|
April 3, 2019
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes
Baris Gencer, Fabio Rigamonti, David Nanchen, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Atherosclerosis
|
January 14, 2015
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes
Baris Gencer, Reto Auer, David Nanchen, et al.
Journal of the American Heart Association
|
November 11, 2017
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes
Baris Gencer, Konstantinos C Koskinas, Lorenz Räber, et al.
Internal and Emergency Medicine
|
February 19, 2022
Eight versus 28-point lung ultrasonography in moderate acute heart failure: a prospective comparative study
Antonio Leidi, Guillaume Soret, Tamara Mann, et al.
AIDS Research and Therapy
|
February 24, 2015
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
David Carballo, Cécile Delhumeau, Sebastian Carballo, et al.
Atherosclerosis Plus
|
October 1, 2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes
Cédric Follonier, Gabriel Rabassa, Mattia Branca, et al.
European Heart Journal
|
February 10, 2011
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity
Alessandra Quercioli, Zoltan Pataky, Gabriella Vincenti, et al.
Plos One
|
March 29, 2014
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications
Reto Auer, Baris Gencer, Lorenz Räber, et al.
European Journal of Preventive Cardiology
|
April 10, 2021
Prognostic value of total testosterone levels in patients with acute coronary syndromes
Baris Gencer, Nicolas Vuilleumier, David Nanchen, et al.
Plos One
|
February 22, 2019
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention
David Carballo, Nicolas Rodondi, Reto Auer, et al.
European Journal of Clinical Investigation
|
April 3, 2019
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes
Baris Gencer, Fabio Rigamonti, David Nanchen, et al.
Page
of 11